Clinical Potential of Copy Number Aberration as a Diagnostic and Prognostic Biomarker in Lymphoma

Xudong Zhang, Zailin Yang, Susu Yan, Minning Zhan, Shichun Tu, Weihong Ren, Yao Liu, Zunmin Zhu

Open source

DOI: 10.1177/15330338251383634
Published: 2025-09
Container: Technology in Cancer Research & Treatment
Publisher: SAGE Publications
Open access: unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

supportingDOI registered: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
supportingDOI resolves: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
supportingMetadata completeness: All 6 scored descriptive metadata groups are present. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1177/15330338251383634,
  title = {Clinical Potential of Copy Number Aberration as a Diagnostic and Prognostic Biomarker in Lymphoma},
  author = {Xudong Zhang and Zailin Yang and Susu Yan and Minning Zhan and Shichun Tu and Weihong Ren and Yao Liu and Zunmin Zhu},
  year = {2025},
  journal = {Technology in Cancer Research \&amp; Treatment},
  doi = {10.1177/15330338251383634},
  url = {https://doi.org/10.1177/15330338251383634}
}

RIS

TY  - JOUR
TI  - Clinical Potential of Copy Number Aberration as a Diagnostic and Prognostic Biomarker in Lymphoma
AU  - Xudong Zhang
AU  - Zailin Yang
AU  - Susu Yan
AU  - Minning Zhan
AU  - Shichun Tu
AU  - Weihong Ren
AU  - Yao Liu
AU  - Zunmin Zhu
PY  - 2025
JO  - Technology in Cancer Research &amp; Treatment
DO  - 10.1177/15330338251383634
UR  - https://doi.org/10.1177/15330338251383634
ER  -

APA

Zhang, X., Yang, Z., Yan, S., Zhan, M., Tu, S., Ren, W., Liu, Y., & Zhu, Z. (2025). Clinical Potential of Copy Number Aberration as a Diagnostic and Prognostic Biomarker in Lymphoma. Technology in Cancer Research & Treatment. https://doi.org/10.1177/15330338251383634

Source records

crossref · retrieved 2026-09-26T19:41:19.446Z